Medicare Enrolled

Dr. Daniel Mollengarden, MD

Urology Physician · Marietta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
55 WHITCHER ST NE STE 250, Marietta, GA 30060
7704284475
In practice since 2014 (12 years)
NPI: 1841619152 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mollengarden from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mollengarden? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mollengarden

Dr. Daniel Mollengarden is an urology physician in Marietta, GA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Mollengarden performed 654 Medicare services across 575 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mollengarden received a total of $5,019 from 32 pharmaceutical and/or device companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mollengarden is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ 654 Medicare services $5,019 industry payments

Medicare Practice Summary

Medicare Utilization ↗
654
Medicare services
Bottom 24% in GA for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
575
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~54 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
181 $2 $12
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
129 $94 $282
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
71 $7 $67
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
51 $115 $375
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
45 $61 $196
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
42 $58 $632
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
35 $64 $182
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
21 $99 $685
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
18 $99 $348
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
17 $57 $255
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
17 $24 $79
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
15 $89 $1,535
Abdominal X-ray, 1 view
An X-ray image of the abdomen taken from a single angle to visualize internal structures.
12 $13 $49
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
19.3% medium
78.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,019
Total received (2019-2024)
Avg $836/year across 6 years
Top 46% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
88
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,019 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,253
2023
$2,619
2022
$382
2021
$208
2020
$303
2019
$254

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$732
Medtronic, Inc.
$78
Edap Technomed Inc
$72
Merck Sharp & Dohme LLC
$61
Sumitomo Pharma America, Inc.
$55
Endo USA, Inc.
$46
Myriad Genetic Laboratories, Inc.
$31
PFIZER INC.
$28
Dendreon Pharmaceuticals LLC
$28
C. R. Bard, Inc. & Subsidiaries
$26
Antares Pharma, Inc.
$23
Ferring Pharmaceuticals Inc.
$21
ABBVIE INC.
$19
Ambu Inc.
$17
Innovation Technologies Inc
$14
Top 3 companies account for 70.4% of 2024 payments
All-time payments by company (2019-2024) ›
Boston Scientific Corporation
$2,657
PROCEPT BioRobotics Corporation
$292
Dendreon Pharmaceuticals LLC
$193
BOSTON SCIENTIFIC CORPORATION
$177
Teleflex LLC
$163
Astellas Pharma US Inc
$146
Laborie Medical Technologies Corp.
$141
Merck Sharp & Dohme LLC
$137
Myovant Sciences Inc.
$130
Sumitomo Pharma America, Inc.
$105
Ethicon US, LLC
$91
Janssen Biotech, Inc.
$87
Medtronic, Inc.
$78
Edap Technomed Inc
$72
Stryker Corporation
$68
C. R. Bard, Inc. & Subsidiaries
$62
Bayer Healthcare Pharmaceuticals Inc.
$54
Ambu Inc.
$48
Endo USA, Inc.
$46
Myriad Genetic Laboratories, Inc.
$31
Becton, Dickinson and Company
$29
PFIZER INC.
$28
Antares Pharma, Inc.
$23
KARL STORZ Endoscopy-America
$21
Ferring Pharmaceuticals Inc.
$21
Agiliti Surgical, Inc.
$21
ABBVIE INC.
$19
Hollister Incorporated
$19
Endo Pharmaceuticals Inc.
$16
ROCHESTER MEDICAL CORPORATION
$15
Innovation Technologies Inc
$14
SRS Medical Systems, Inc.
$13
Top 3 companies account for 62.6% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AVEED · Bard Urinary Drainage Bag · CERTUS 140 MICROWAVE ABLATION SYSTEM · ERLEADA · FLEXIVA · FLUID MANAGEMENT SYSTEM · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL - THERAPIES · INTERSTIM · IRRISEPT · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LithoVue · Lumenis Pulse 100H · Lumenis Pulse 120H · MYRBETRIQ · Moses 550 D\F\L · Myrbetriq · Nubeqa · ORGOVYX · PROLARIS · PROVENGE · SPACEOAR · Sonablate · TRIA · TRICAM · UROLIFT · UroCuff · VaPro · XIAFLEX · XTANDI · XYOSTED · Xpeeda DSL Fiber
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Marietta?
Compare urology physicians in the Marietta area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
142
Per 100K population
18.5
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mollengarden is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mollengarden experienced with automated urinalysis?
Based on Medicare claims data, Dr. Mollengarden performed 181 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mollengarden receive payments from pharmaceutical companies?
Yes. Dr. Mollengarden received a total of $5,019 from 32 companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mollengarden's costs compare to other urology physicians in Marietta?
Dr. Mollengarden's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mollengarden) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →